Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib.
Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib. Blood. 2012 Jul 12; 120(2):291-4.